Steve Mogensen is a seasoned medical device professional with over 25 years of experience in the medical device industry. Currently Mr. Mogensen serves as the President & CEO of SpeechVive, Inc. Previously Mr. Mogensen served as Managing Director of the Alfred Mann Institute at Purdue University, Vice President of Sales and Marketing at Enpath Medical which sold to Greatbatch Inc. in June, 2007, President and Co-Founder of Advanced Clinical Services, Inc., Vice President NPI at MedSource Technologies which went public in February 2002, and over 11 years at Smiths Medical in 7 roles.
Director & Chief Technology Officer
Jessica Huber received her Ph.D. in Speech Science from the University at Buffalo - State University of New York in June 2001. She joined the Department of Speech, Language, and Hearing Sciences at Purdue University in Fall 2001. Professor Huber’s primary area of research is speech motor control in both normal individuals and individuals with motor speech disorders, in particular Parkinson’s disease. Current research projects include studies of the effects of speech treatments, dopaminergic drugs, and deep-brain stimulation on speech in Parkinson’s disease. Doctor Huber currently serves as a Director and as Chief Technology Officer for SpeechVive, Inc.